Ovarian cancer
Introduction
 Ovarian cancer is the second most common gynaecological malignancy
 the major cause of death from gynaecological cancer
 Usually discovered late ( present in advanced stages )
 No effective screening method
 Life time risk is 1:70 (1.4 %)
 The mean age of presentation is 64
 Mean age of diagnosis is 54
 The most common type is epithelial
 More in old age , white , family history of ovarian and breast cancer , nulliparas
 OCP , hysterectomy and salpingectomy are protective
Classification of ovarian cancer
Epithelial tumors
 Benign , borderline and malignant
 Borderline tumors (10 % , well differentiated and doesn’t invade the basement
membranes, spread locally, surgery is the treatment of choice , mostly serous)
 Mucinous: may rise from GIT origin, multiloculated and lead to pseudomyxoma
peritoneii.
 Serous : the most common type , characterized histologically by concentric
rings of calcification, known as ā€˜psammoma bodies
 Endometroid : histologically similar to endometrial cance , 10 % with endometrial
cancer too
 Clear cell : similar to renal cells , endometriosis increase the risk of this type
Risk factors
Hereditary :
10 % of cases
BRCA1 (80% risk) and BRCA 2(15 %
risk) gene mutation + high risk for breast
cancer
LYNCH syndrome (HNPCC) with risk of
colon cancer , uterine cancer and 10 %
risk of ovarian cancer
Preventing ovarian cancer
 prophylactic salpengoophorectomy :
Women who test positive for a BRCA mutation are offered risk-reducing prophylactic BSO
when they have completed their families (mid-30s in BRCA1 ) and (early 40s in BRCA 2
carriers )
Other methods decreases the risk :
Salpingectomy
Hysterectomy
OCP
Clinical picture
 Usually late and vague (GI or urinary symptoms )
 The most common symptoms are:
• Increased abdominal girth/bloating.
• Persistent pelvic and abdominal pain.
• Difficulty eating and feeling full quickly.
Investigations
 Ultrasound (TVUS )
 Tumor markers
 RMI (risk of malignancy index)
Staging
 Staged SURGICALLY
Management
 Chemotherapy and surgery when operable
Prognosis
The most important prognostic
factor is RESIDUAL AFTER
SURGERY

L44 Ovarian cancer

  • 1.
  • 2.
    Introduction  Ovarian canceris the second most common gynaecological malignancy  the major cause of death from gynaecological cancer  Usually discovered late ( present in advanced stages )  No effective screening method  Life time risk is 1:70 (1.4 %)  The mean age of presentation is 64  Mean age of diagnosis is 54  The most common type is epithelial  More in old age , white , family history of ovarian and breast cancer , nulliparas  OCP , hysterectomy and salpingectomy are protective
  • 3.
  • 4.
    Epithelial tumors  Benign, borderline and malignant  Borderline tumors (10 % , well differentiated and doesn’t invade the basement membranes, spread locally, surgery is the treatment of choice , mostly serous)  Mucinous: may rise from GIT origin, multiloculated and lead to pseudomyxoma peritoneii.  Serous : the most common type , characterized histologically by concentric rings of calcification, known as ā€˜psammoma bodies  Endometroid : histologically similar to endometrial cance , 10 % with endometrial cancer too  Clear cell : similar to renal cells , endometriosis increase the risk of this type
  • 5.
    Risk factors Hereditary : 10% of cases BRCA1 (80% risk) and BRCA 2(15 % risk) gene mutation + high risk for breast cancer LYNCH syndrome (HNPCC) with risk of colon cancer , uterine cancer and 10 % risk of ovarian cancer
  • 6.
    Preventing ovarian cancer prophylactic salpengoophorectomy : Women who test positive for a BRCA mutation are offered risk-reducing prophylactic BSO when they have completed their families (mid-30s in BRCA1 ) and (early 40s in BRCA 2 carriers ) Other methods decreases the risk : Salpingectomy Hysterectomy OCP
  • 7.
    Clinical picture  Usuallylate and vague (GI or urinary symptoms )  The most common symptoms are: • Increased abdominal girth/bloating. • Persistent pelvic and abdominal pain. • Difficulty eating and feeling full quickly.
  • 8.
    Investigations  Ultrasound (TVUS)  Tumor markers  RMI (risk of malignancy index)
  • 9.
  • 10.
  • 11.
    Prognosis The most importantprognostic factor is RESIDUAL AFTER SURGERY